Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Search for unknown tumor-antagonizing genes.

Stephan Imreh1, George Klein, Eugene R Zabarovsky

  • 1Karolinska Institutet, Microbiology and Tumor Biology Center, Stockholm, Sweden.

Genes, Chromosomes & Cancer
|October 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of the surface electrocardiogram RP interval cutoff for diagnosis of atrioventricular nodal reentrant tachycardia.

Journal of electrocardiology·2025
Same author

Understanding differential pacing: Unraveling the pitfalls of base versus apex pacing in distinguishing AVNRT from AVRT over a septal AP.

Journal of cardiovascular electrophysiology·2024
Same author

Approach to a patient with asymptomatic pre-excitation.

Heart (British Cardiac Society)·2023
Same author

Double chamber cross-talk, the ultimate double-cross.

Pacing and clinical electrophysiology : PACE·2020
Same author

Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?

American heart journal·2020
Same author

Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2.

Proceedings of the National Academy of Sciences of the United States of America·2020

Researchers identified novel tumor suppressor genes on human chromosome 3p21.3 using unconventional methods. These findings suggest a broader role for multiple genes in preventing uncontrolled cell proliferation and cancer development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The discovery of the first tumor suppressor gene, RB1, confirmed Alfred Knudson's hypothesis and highlighted the role of cell cycle control.
  • Loss of heterozygosity (LOH) and other genomic techniques have been crucial in identifying tumor suppressor genes involved in cell cycle and apoptosis regulation.
  • Evidence suggests numerous, potentially unknown, genes contribute to preventing malignant growth, supported by widespread genomic losses in tumors.

Purpose of the Study:

  • To investigate novel tumor-antagonizing genes, particularly within the frequently deleted human chromosomal subband 3p21.3.
  • To explore unconventional approaches for identifying genes that suppress tumorigenicity.

Main Methods:

  • Utilized deletion mapping and the "elimination test" to analyze human chromosomal subband 3p21.3.

Related Experiment Videos

  • Focused on a region frequently targeted by cytogenetically detectable deletions.
  • Employed hybridizing malignant cells with non-tumorigenic cells to study suppression of the malignant phenotype.

    • Main Results:

    • Identified four distinct clusters of candidate tumor suppressor genes located at 3p21.3.
    • The "elimination test" and deletion mapping pinpointed these gene clusters.
    • Confirmed that the suppression of tumorigenicity can occur without assigning it to a single gene.

    Conclusions:

    • The number and diversity of genes protecting against uncontrolled proliferation may be underestimated.
    • Human chromosomal subband 3p21.3 harbors multiple candidate tumor suppressor genes.
    • Further research into these novel genes could reveal new therapeutic targets for cancer treatment.